found that EGF activations of downstream integrin signaling pathways in breast cancer adenocarcinoma epithelial cells induces tumor metastasis dependent on synergistic actions of Galectin 3 and p-Caveolin-1 (221). The gene discussed is CAV1; the disease is neoplasm.